CFDE Data Portal | Search GAPDHP46

	Label	Description
	GAPDHP46 associations Collection (Entity type)	Associations for GAPDHP46_associations
	GAPDHP46 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GAPDHP46 Gene (Entity type)	ENSG00000224678 - glyceraldehyde 3 phosphate dehydrogenase pseudogene 46
	GSE182710 Drp1 TFAM overexpression 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199107 tryptophan 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE79395 ADNP knockdown HCT 116 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	PANK3 IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GTEx Thyroid 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Stomach 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Pituitary 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx

GAPDHP46 associations

Associations for GAPDHP46_associations

GAPDHP46 associations.tsv

A file from IDG as part of the Harmonizome project

GAPDHP46

ENSG00000224678 - glyceraldehyde 3 phosphate dehydrogenase pseudogene 46

GSE182710 Drp1 TFAM overexpression 1 v 2 human dn

A Gene Set from LINCS

GSE199107 tryptophan 4 v 5 human dn

A Gene Set from LINCS

GSE79395 ADNP knockdown HCT 116 0 v 1 human dn

A Gene Set from LINCS

PANK3 IDG kinase ARCHS4 coexpression

A Gene Set from IDG

GTEx Thyroid 20-29 vs 30-39 Down

A Gene Set from GTEx

GTEx Stomach 20-29 vs 70-79 Up

A Gene Set from GTEx

GTEx Pituitary 20-29 vs 40-49 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.